Tag: Boehringer Ingelheim
Boehringer Ingelheim partners with CBmed to advance cancer therapies
GERMANY – Boehringer Ingelheim, a leading pharmaceutical company, has announced a strategic...
Read More
Boehringer Ingelheim injects over US$131M into Koropi manufacturing site
GERMANY – Boehringer Ingelheim has invested €120 million (US$131.6 million) for the extension of...
Read More
Boehringer Ingelheim leverages IBM’s AI for accelerated antibody discovery
GERMANY — Boehringer Ingelheim has entered into an agreement with IBM to harness the power of...
Read More
Boehringer Ingelheim acquires T3 Pharma to advance innovative bacterial cancer therapy platform
GERMANY — In a strategic move to strengthen its cancer pipeline, Boehringer Ingelheim, a leading...
Read More
Boehringer Ingelheim unveils vibrant rebrand with a message of progress
GERMANY — Boehringer Ingelheim, the German pharmaceutical giant known for its notable products...
Read More
Lupin Limited snaps up Boehringer Ingelheim’s diabetes brands to expand its product portfolio in India
INDIA – Lupin Limited has finalized the acquisition of two diabetes brands, ONDERO and ONDERO MET,...
Read More
Boehringer Ingelheim joins ranks challenging Medicare’s drug pricing authority
USA— The arena of pharmaceutical pricing is witnessing a growing legal skirmish as Boehringer...
Read More
Boehringer Ingelheim ventures into late-stage trials for innovative GLP-1-based drug
GERMANY — Boehringer Ingelheim, a pioneering pharmaceutical force, is intensifying its pursuit of...
Read More
Boehringer Ingelheim appoints César Nieto to lead its expansion ambitions in Sub-Saharan Africa
SOUTH AFRICA – Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, has...
Read More
Boehringer Ingelheim India picks Gagandeep Singh as its new MD & Head of Human Pharma
INDIA – Global drug firm Boehringer Ingelheim has hired Gagandeep Singh Bedi as the company’s new...
Read More
Boehringer Ingelheim’s claim against Sanofi dismissed in Zantac legal battle
USA — An arbitration tribunal of the International Chamber of Commerce has ruled in favor of...
Read More
Boehringer Ingelheim taps Ginkgo Bioworks for drug discovery deal worth up to US$406M
USA — Ginkgo Bioworks has entered into a partnership with Boehringer Ingelheim, a German...
Read More
LATEST DIGITAL MAGAZINE
